These potential structural mutants may stem from the fusion of FAK and TRAPPC9 genes, according to the genomic profile of FAK in the panel of cancer cell lines described in the Encyclopedia [30, 63] or the CRC cohort in the TCGA database from our cBioPortal‐based analysis (data not shown). This evidence concerns the gene PTK2 and colorectal carcinoma.